| scholarly article | Q13442814 |
| P2093 | author name string | José M Villalba | |
| Francisco J Alcaín | |||
| P2860 | cites work | Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase. | Q46462678 |
| Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. | Q46656918 | ||
| Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells | Q46709814 | ||
| Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors | Q46815953 | ||
| Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins) | Q58844844 | ||
| Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment | Q82686511 | ||
| Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins | Q83391665 | ||
| Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network | Q84086369 | ||
| What is new for an old molecule? Systematic review and recommendations on the use of resveratrol | Q21089966 | ||
| hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase | Q24291829 | ||
| SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity | Q24294017 | ||
| The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase | Q24296836 | ||
| Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase | Q24297207 | ||
| Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle | Q24299947 | ||
| Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis | Q24338619 | ||
| Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription | Q24546024 | ||
| Sir2 mediates longevity in the fly through a pathway related to calorie restriction | Q24560016 | ||
| AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity | Q24595845 | ||
| Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases | Q24608197 | ||
| SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells | Q24626021 | ||
| SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator | Q24626329 | ||
| SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 | Q24633063 | ||
| Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription | Q24633178 | ||
| Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes | Q24645537 | ||
| Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span | Q24649811 | ||
| SIRT1 regulates HIV transcription via Tat deacetylation | Q24797263 | ||
| Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin | Q27644043 | ||
| Resveratrol improves health and survival of mice on a high-calorie diet | Q27860950 | ||
| Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae | Q27933365 | ||
| The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases | Q27934108 | ||
| Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans | Q28131824 | ||
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | Q28203572 | ||
| Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene | Q28205723 | ||
| Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening | Q28210511 | ||
| SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} | Q28235481 | ||
| Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 | Q28237795 | ||
| Mechanism of human SIRT1 activation by resveratrol | Q28238262 | ||
| Sirtuin activators | Q28244893 | ||
| Resveratrol is not a direct activator of SIRT1 enzyme activity | Q28261917 | ||
| SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis | Q28279273 | ||
| Substrate-specific activation of sirtuins by resveratrol | Q28305166 | ||
| Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease | Q28307422 | ||
| Identification of a small molecule inhibitor of Sir2p | Q28344005 | ||
| Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 | Q28509079 | ||
| SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity | Q28512048 | ||
| Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1 | Q28512371 | ||
| Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin | Q28572741 | ||
| SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis | Q28583941 | ||
| Sirtuin activators mimic caloric restriction and delay ageing in metazoans | Q29547766 | ||
| Sirtuins in mammals: insights into their biological function | Q29615248 | ||
| Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans | Q32774312 | ||
| Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo | Q33417863 | ||
| SIRT6 promotes DNA repair under stress by activating PARP1 | Q33803766 | ||
| SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells | Q33861978 | ||
| Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells | Q34023370 | ||
| Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling | Q34024056 | ||
| High absorption but very low bioavailability of oral resveratrol in humans | Q34343815 | ||
| A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. | Q34388936 | ||
| Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction | Q34534198 | ||
| Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. | Q34622062 | ||
| Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila | Q34632518 | ||
| Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice | Q34743879 | ||
| Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells. | Q34747946 | ||
| Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. | Q35050748 | ||
| Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics | Q35215147 | ||
| Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells | Q35337908 | ||
| Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis | Q35802231 | ||
| Sirtuin modulators | Q36165220 | ||
| New agents in intravesical chemotherapy of superficial bladder cancer | Q36194981 | ||
| SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome | Q36491908 | ||
| Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle | Q36739504 | ||
| Brain SIRT1: anatomical distribution and regulation by energy availability | Q36962837 | ||
| The Sirtuin family: therapeutic targets to treat diseases of aging | Q37087540 | ||
| Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice | Q37097951 | ||
| Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity | Q37139750 | ||
| SirT1 is an inhibitor of proliferation and tumor formation in colon cancer | Q37258577 | ||
| Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells | Q37295559 | ||
| Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. | Q37343700 | ||
| Sirtuin inhibitors. | Q37481259 | ||
| Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia | Q37600341 | ||
| Role of Sirtuin 1 in metabolic regulation | Q37771695 | ||
| Medicinal chemistry of sirtuin inhibitors | Q37868632 | ||
| Fine tuning our cellular factories: sirtuins in mitochondrial biology | Q37884948 | ||
| Regulation and protection of mitochondrial physiology by sirtuins. | Q37905267 | ||
| Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators | Q38356805 | ||
| SIRT2 activity is required for the survival of C6 glioma cells | Q39429048 | ||
| SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183. | Q39572061 | ||
| SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. | Q39718199 | ||
| Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. | Q39805050 | ||
| Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors | Q39815436 | ||
| Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity. | Q39856102 | ||
| Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging. | Q39875452 | ||
| Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. | Q39908136 | ||
| A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells | Q39969180 | ||
| Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode | Q40013998 | ||
| SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents | Q40209315 | ||
| Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes | Q40291559 | ||
| The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells | Q41916312 | ||
| Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition | Q42008823 | ||
| Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. | Q42677167 | ||
| Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues | Q43205019 | ||
| Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity | Q43506305 | ||
| Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry | Q44537505 | ||
| Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators | Q46080032 | ||
| Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation | Q46220928 | ||
| Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart | Q46460770 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 349-359 | |
| P577 | publication date | 2012-06-25 | |
| P1433 | published in | BioFactors | Q15767404 |
| P1476 | title | Sirtuin activators and inhibitors | |
| P478 | volume | 38 |
| Q92955278 | A Comparative Linear Interaction Energy and MM/PBSA Study on SIRT1-Ligand Binding Free Energy Calculation |
| Q33636551 | A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells |
| Q91415733 | A Small-Molecule SIRT2 Inhibitor That Promotes K-Ras4a Lysine Fatty-Acylation |
| Q39147132 | A chemical probe toolbox for dissecting the cancer epigenome |
| Q41889644 | A fluorogenic assay for screening Sirt6 modulators |
| Q55098610 | A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity. |
| Q59794685 | A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model |
| Q49571085 | Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity. |
| Q36299758 | Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents. |
| Q35897811 | Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis |
| Q28389419 | Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system |
| Q46277387 | Alterations of sirtuins in mitochondrial cytochrome c-oxidase deficiency |
| Q37081627 | Alterations of ultrastructural and fission/fusion markers in hepatocyte mitochondria from mice following calorie restriction with different dietary fats. |
| Q41155454 | An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3. |
| Q37513949 | Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding |
| Q38285137 | Anticancer agents targeted to sirtuins |
| Q52945494 | Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma. |
| Q33943997 | Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy |
| Q58093768 | Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer |
| Q38187003 | Circadian clocks and energy metabolism |
| Q37544742 | Comparative effects of histone deacetylases inhibitors and resveratrol on Trypanosoma cruzi replication, differentiation, infectivity and gene expression |
| Q99207639 | Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia |
| Q64236077 | Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting |
| Q64951384 | Do p53 stress responses impact organismal aging? |
| Q35208102 | Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis |
| Q57030415 | Effect of Resveratrol, a Dietary-Derived Polyphenol, on the Oxidative Stress and Polyol Pathway in the Lens of Rats with Streptozotocin-Induced Diabetes |
| Q47774577 | Effects of resveratrol on high-fructose-induced testis injury in rats. |
| Q47115527 | Epigenetic Regulatory Mechanisms Induced by Resveratrol. |
| Q34431964 | Epigenetic drugs against cancer: an evolving landscape |
| Q92385147 | Epigenetics in age-related macular degeneration: new discoveries and future perspectives |
| Q88559187 | Exploration of the Fluorescent Properties and the Modulated Activities against Sirtuin Fluorogenic Assays of Chromenone-Derived Natural Products |
| Q52957348 | Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells. |
| Q35960986 | Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor |
| Q37384514 | Functional complementation of sir2Δ yeast mutation by the human orthologous gene SIRT1. |
| Q92246311 | H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy |
| Q90113863 | Hypothalamic NAD+-Sirtuin Axis: Function and Regulation |
| Q26750982 | In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins |
| Q35513609 | Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice |
| Q30234757 | Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease. |
| Q33835913 | Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches |
| Q90422160 | Investigating the role of Sirtuins in cell reprogramming |
| Q34525541 | Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma |
| Q38248057 | Mediterranean Way of Drinking and Longevity |
| Q38736064 | Mediterranean diet and inflammaging within the hormesis paradigm |
| Q92815195 | Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1 |
| Q55393389 | Melatonin Treatment Regulates SIRT3 Expression in Early Brain Injury (EBI) Due to Reactive Oxygen Species (ROS) in a Mouse Model of Subarachnoid Hemorrhage (SAH). |
| Q64279473 | Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells |
| Q38838565 | Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential |
| Q41288627 | Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy |
| Q27330338 | Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activity |
| Q38081415 | Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression? |
| Q38739347 | Multitarget Drugs: an Epigenetic Epiphany. |
| Q91746797 | NAD metabolites interfere with proliferation and functional properties of THP-1 cells |
| Q64272978 | Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease |
| Q35792091 | Novel sirtuin inhibitory warheads derived from the N(ε)-acetyl-lysine analog L-2-amino-7-carboxamidoheptanoic acid |
| Q39172757 | Nutrient sensing pathways as therapeutic targets for healthy ageing |
| Q38104777 | Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population. |
| Q55343520 | Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury. |
| Q61807037 | Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages |
| Q90418958 | Partially Hydrolyzed Guar Gum Attenuates d-Galactose-Induced Oxidative Stress and Restores Gut Microbiota in Rats |
| Q40144743 | Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene |
| Q37008516 | Prolactin protects retinal pigment epithelium by inhibiting sirtuin 2-dependent cell death |
| Q91151930 | Protective effects of seaweed supplemented diet on antioxidant and immune responses in European seabass (Dicentrarchus labrax) subjected to bacterial infection |
| Q27023972 | Redox regulation of SIRT1 in inflammation and cellular senescence |
| Q28546833 | Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation |
| Q39694748 | Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model |
| Q34357570 | Resveratrol in metabolic health: an overview of the current evidence and perspectives. |
| Q55026202 | Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production. |
| Q43084482 | Resveratrol, a sirtuin 1 activator, increases IL-6 production by peripheral blood mononuclear cells of patients with knee osteoarthritis |
| Q42701542 | Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity |
| Q46276226 | Role of Beta-adrenergic Receptors and Sirtuin Signaling in the Heart During Aging, Heart Failure, and Adaptation to Stress |
| Q54970037 | SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. |
| Q91690834 | SIRT1 Modulators in Experimentally Induced Liver Injury |
| Q37371484 | SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway |
| Q36169626 | SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease |
| Q37526864 | SIRT3 Expression Decreases with Reactive Oxygen Species Generation in Rat Cortical Neurons during Early Brain Injury Induced by Experimental Subarachnoid Hemorrhage. |
| Q48134740 | SIRT7 Is an RNA-Activated Protein Lysine Deacylase |
| Q38309390 | Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning |
| Q90320971 | Sirt1 protects from K-Ras-driven lung carcinogenesis |
| Q35065727 | Sirtinol inhibits neutrophil elastase activity and attenuates lipopolysaccharide-mediated acute lung injury in mice |
| Q92607821 | Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-κB and expression of the long-noncoding RNA HAS2-AS1 |
| Q94562985 | Sirtuin 1: A Dilemma in Transplantation |
| Q40052222 | Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal Infection |
| Q33818987 | Sirtuin 3 deficiency does not alter host defenses against bacterial and fungal infections |
| Q59791584 | Sirtuin 5 Deficiency Does Not Compromise Innate Immune Responses to Bacterial Infections |
| Q26745884 | Sirtuin functions and modulation: from chemistry to the clinic |
| Q37150523 | Sirtuin-3 (SIRT3) and the Hallmarks of Cancer |
| Q37710177 | Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders |
| Q28079953 | Sirtuins and nonalcoholic fatty liver disease |
| Q35768345 | Sirtuins, aging, and cardiovascular risks |
| Q37673310 | Small molecule SIRT1 activators for the treatment of aging and age-related diseases |
| Q40834621 | Suppressive effects of sirtinol on human cytomegalovirus (hCMV) infection and hCMV-induced activation of molecular mechanisms of senescence and production of reactive oxygen species |
| Q35907645 | Systemic regulation of mammalian ageing and longevity by brain sirtuins |
| Q38714925 | Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND. |
| Q40649592 | The Effects of Class-Specific Histone Deacetylase Inhibitors on the Development of Limbs During Organogenesis |
| Q48104396 | The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition |
| Q59792854 | The Regulation of JNK Signaling Pathways in Cell Death through the Interplay with Mitochondrial SAB and Upstream Post-Translational Effects |
| Q33602912 | The Synergistic Role of Light-Feeding Phase Relations on Entraining Robust Circadian Rhythms in the Periphery |
| Q33554869 | The class III histone deacetylase sirtuin 1 in immune suppression and its therapeutic potential in rheumatoid arthritis |
| Q36012249 | The influence of dietary fat source on liver and skeletal muscle mitochondrial modifications and lifespan changes in calorie-restricted mice |
| Q49964101 | The protein acyltransferase Pat post-transcriptionally controls HilD to repress Salmonella invasion |
| Q38184501 | The sirtuin class of histone deacetylases: regulation and roles in lipid metabolism |
| Q57113225 | Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto's Thyroiditis and Differentiated Thyroid Cancer |
| Q38152454 | p53 as an intervention target for cancer and aging |
Search more.